Find Valbenazine Tosylate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Valbenazine ditosylate, 1639208-54-0, Valbenazine tosilate, Valbenazine (tosylate), Nbi-98854 ditosylate, Valbenazine tosylate [usan]
Molecular Formula
C38H54N2O10S2
Molecular Weight
763.0  g/mol
InChI Key
BXGKAGLZHGYAMW-TZYFFPFWSA-N
FDA UNII
5SML1T733B

Valbenazine Tosylate
1 2D Structure

Valbenazine Tosylate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[(2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] (2S)-2-amino-3-methylbutanoate;4-methylbenzenesulfonic acid
2.1.2 InChI
InChI=1S/C24H38N2O4.2C7H8O3S/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4;2*1-6-2-4-7(5-3-6)11(8,9)10/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3;2*2-5H,1H3,(H,8,9,10)/t17-,19-,20-,23+;;/m1../s1
2.1.3 InChI Key
BXGKAGLZHGYAMW-TZYFFPFWSA-N
2.1.4 Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC
2.1.5 Isomeric SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)C[C@@H]1CN2CCC3=CC(=C(C=C3[C@H]2C[C@H]1OC(=O)[C@H](C(C)C)N)OC)OC
2.2 Other Identifiers
2.2.1 UNII
5SML1T733B
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Valbenazine Ditosylate

2. 1639208-54-0

3. Valbenazine Tosilate

4. Valbenazine (tosylate)

5. Nbi-98854 Ditosylate

6. Valbenazine Tosylate [usan]

7. 5sml1t733b

8. 1639208-54-0 (tosylayte)

9. Valbenazine Tosilate (jan)

10. Valbenazine Tosylate (usan)

11. Valbenazine Tosilate [jan]

12. (2r,3r,11br)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-yl L-valinate Di(4-methylbenzenesulfonate)

13. L-valine, (2r,3r,11br)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2h-benzo(a)quinolizin-2-yl Ester, 4-methylbenzenesulfonate (1:2)

14. Ingrezza (tn)

15. Nbi-98854 Tosylate

16. Unii-5sml1t733b

17. Valbenazine Tosylate (1:2)

18. Chembl3707248

19. Schembl18863051

20. Valbenazine Tosylate [mi]

21. Dtxsid201026308

22. Hy-16771a

23. S9500

24. Valbenazine Tosilate [who-dd]

25. Ccg-270445

26. Valbenazine Tosylate [orange Book]

27. Cs-0030913

28. D10999

29. Q27262815

30. (2r,3r,11br)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizin-2-yl L-valinate Bis(4-methylbenzenesulfonate)

31. [(2r,3r,11br)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1h-benzo[a]quinolizin-2-yl] (2s)-2-amino-3-methylbutanoate;4-methylbenzenesulfonic Acid

2.4 Create Date
2015-11-09
3 Chemical and Physical Properties
Molecular Weight 763.0 g/mol
Molecular Formula C38H54N2O10S2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count12
Rotatable Bond Count10
Exact Mass762.32198827 g/mol
Monoisotopic Mass762.32198827 g/mol
Topological Polar Surface Area200 Ų
Heavy Atom Count52
Formal Charge0
Complexity776
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Drug and Medication Information
4.1 Drug Information
1 of 1  
Drug NameINGREZZA
Active IngredientVALBENAZINE TOSYLATE
CompanyNEUROCRINE (Application Number: N209241. Patents: 8039627, 8357697)

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1696617000,"product":"VALBENAZINE TOSYLATE, BATCH NO.10607645","address":"159, C.S.T. ROAD,","city":"MUMBAI,MAHARASHTRA","supplier":"LUPIN LTD","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"F & A. PHARMA-HANDELS-GMBH","customerCountry":"GERMANY","quantity":"0.02","actualQuantity":"0.015","unit":"KGS","unitRateFc":"350000","totalValueFC":"5166.5","currency":"USD","unitRateINR":28666666.666666668,"date":"07-Oct-2023","totalValueINR":"430000","totalValueInUsd":"5166.5","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4459256","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"159, C.S.T. ROAD,, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1722364200,"product":"VALBENAZINE TOSYLATE","address":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL","city":"HYDERABAD, AP","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"EVEREST PHARMACEUTICALS LIMITED","customerCountry":"BANGLADESH","quantity":"6.76","actualQuantity":"6.76","unit":"KGS","unitRateFc":"9000","totalValueFC":"60202.1","currency":"USD","unitRateINR":744432.24852071004,"date":"31-Jul-2024","totalValueINR":"5032362","totalValueInUsd":"60202.1","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"2859260","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"PLOT NO.C-24, MSN HOUSE, INDUSTRIAL, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1674412200,"product":"4001288 VALBENAZINE TOSYLATE","address":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI","city":"GARDEN CITY OFF WESTERN EXPR HIGHWA","supplier":"CHEMICAL INDUSTRIES ASSOCIATION","supplierCountry":"ISRAEL","foreign_port":"NA","customer":"TEVA PHARMACEUTICAL INDUSTRIES","customerCountry":"INDIA","quantity":"25.50","actualQuantity":"25.5","unit":"KGS","unitRateFc":"3290","totalValueFC":"101339.6","currency":"USD","unitRateINR":"324920.4","date":"23-Jan-2023","totalValueINR":"8285470.2","totalValueInUsd":"101339.6","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"4320593","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ISRAEL","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"12TH FLOOR, COMMERZ II,,INTERNATIO NAL BUSNESS PARK,OBEROI"}]
23-Jan-2023
31-Jul-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
euroPLX 86 Munich
Not Confirmed

NEUROCRINE

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

VALBENAZINE TOSYLATE

US Patent Number : 10993941

Drug Substance Claim :

Drug Product Claim :

Application Number : 209241

Patent Use Code : U-1995

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

02

arrow
euroPLX 86 Munich
Not Confirmed

NEUROCRINE

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

VALBENAZINE TOSYLATE

US Patent Number : 10844058

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209241

Patent Use Code : U-3055

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-10-28

blank

03

arrow
euroPLX 86 Munich
Not Confirmed

NEUROCRINE

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

VALBENAZINE TOSYLATE

US Patent Number : 10993941

Drug Substance Claim :

Drug Product Claim :

Application Number : 218390

Patent Use Code : U-1995

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

04

arrow
euroPLX 86 Munich
Not Confirmed

NEUROCRINE

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

VALBENAZINE TOSYLATE

US Patent Number : 10952997

Drug Substance Claim :

Drug Product Claim :

Application Number : 209241

Patent Use Code : U-1995

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

05

arrow
euroPLX 86 Munich
Not Confirmed

NEUROCRINE

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

VALBENAZINE TOSYLATE

US Patent Number : 10851104

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 218390

Patent Use Code : U-1995

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-10-28

blank

06

arrow
euroPLX 86 Munich
Not Confirmed

NEUROCRINE

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

VALBENAZINE TOSYLATE

US Patent Number : 10919892

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209241

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-12-22

blank

07

arrow
euroPLX 86 Munich
Not Confirmed

NEUROCRINE

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

VALBENAZINE TOSYLATE

US Patent Number : 8357697

Drug Substance Claim :

Drug Product Claim :

Application Number : 218390

Patent Use Code : U-1995

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-11-08

blank

08

arrow
euroPLX 86 Munich
Not Confirmed

NEUROCRINE

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

VALBENAZINE TOSYLATE

US Patent Number : 10065952

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 218390

Patent Use Code : U-3055

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-10-28

blank

09

arrow
euroPLX 86 Munich
Not Confirmed

NEUROCRINE

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

VALBENAZINE TOSYLATE

US Patent Number : 8039627

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209241

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-04-11

blank

10

arrow
euroPLX 86 Munich
Not Confirmed

NEUROCRINE

U.S.A
arrow
euroPLX 86 Munich
Not Confirmed

VALBENAZINE TOSYLATE

US Patent Number : 10844058

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 218390

Patent Use Code : U-1995

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-10-28

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

US Exclusivities

read-more
read-more

01

arrow
BioFlorida Conference
Not Confirmed

NEUROCRINE

U.S.A
arrow
BioFlorida Conference
Not Confirmed

VALBENAZINE TOSYLATE

Exclusivity Code : ODE-440

Exclusivity Expiration Date : 2030-08-18

Application Number : 209241

Product Number : 2

Exclusivity Details :

blank

02

arrow
BioFlorida Conference
Not Confirmed

NEUROCRINE

U.S.A
arrow
BioFlorida Conference
Not Confirmed

VALBENAZINE TOSYLATE

Exclusivity Code : I-925

Exclusivity Expiration Date : 2026-08-18

Application Number : 209241

Product Number : 2

Exclusivity Details :

blank

03

arrow
BioFlorida Conference
Not Confirmed

NEUROCRINE

U.S.A
arrow
BioFlorida Conference
Not Confirmed

VALBENAZINE TOSYLATE

Exclusivity Code : ODE-440

Exclusivity Expiration Date : 2030-08-18

Application Number : 209241

Product Number : 1

Exclusivity Details :

blank

04

arrow
BioFlorida Conference
Not Confirmed

NEUROCRINE

U.S.A
arrow
BioFlorida Conference
Not Confirmed

VALBENAZINE TOSYLATE

Exclusivity Code : I-925

Exclusivity Expiration Date : 2026-08-18

Application Number : 209241

Product Number : 1

Exclusivity Details :

blank

05

arrow
BioFlorida Conference
Not Confirmed

NEUROCRINE

U.S.A
arrow
BioFlorida Conference
Not Confirmed

VALBENAZINE TOSYLATE

Exclusivity Code : ODE-440

Exclusivity Expiration Date : 2030-08-18

Application Number : 209241

Product Number : 3

Exclusivity Details :

blank

06

arrow
BioFlorida Conference
Not Confirmed

NEUROCRINE

U.S.A
arrow
BioFlorida Conference
Not Confirmed

VALBENAZINE TOSYLATE

Exclusivity Code : I-925

Exclusivity Expiration Date : 2026-08-18

Application Number : 209241

Product Number : 3

Exclusivity Details :

blank

07

arrow
BioFlorida Conference
Not Confirmed

NEUROCRINE

U.S.A
arrow
BioFlorida Conference
Not Confirmed

VALBENAZINE TOSYLATE

Exclusivity Code : I-925

Exclusivity Expiration Date : 2026-08-18

Application Number : 218390

Product Number : 2

Exclusivity Details :

blank

08

arrow
BioFlorida Conference
Not Confirmed

NEUROCRINE

U.S.A
arrow
BioFlorida Conference
Not Confirmed

VALBENAZINE TOSYLATE

Exclusivity Code : I-925

Exclusivity Expiration Date : 2026-08-18

Application Number : 218390

Product Number : 3

Exclusivity Details :

blank

09

arrow
BioFlorida Conference
Not Confirmed

NEUROCRINE

U.S.A
arrow
BioFlorida Conference
Not Confirmed

VALBENAZINE TOSYLATE

Exclusivity Code : I-925

Exclusivity Expiration Date : 2026-08-18

Application Number : 218390

Product Number : 1

Exclusivity Details :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty